Infliximab therapy provides beneficial effects for choroidal thickness increase in patients with active ankylosing spondylitis: A possible mechanism mediating the suppressing of uveitis attacks


Creative Commons License

KARKUCAK M. , KOLA M. , Kalkisim A. , ÇAPKIN E. , AYAR A. , TÜRK A.

ARCHIVES OF RHEUMATOLOGY, vol.36, no.1, pp.56-62, 2021 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.46497/archrheumatol.2021.7806
  • Title of Journal : ARCHIVES OF RHEUMATOLOGY
  • Page Numbers: pp.56-62
  • Keywords: Ankylosing spondylitis, choroid thickness, infliximab, optical coherence tomography, retinal nerve fiber layer thickness, OPTICAL COHERENCE TOMOGRAPHY, NERVE-FIBER LAYER, ARTERIAL STIFFNESS, ALPHA THERAPY, RECOMMENDATIONS, ASSOCIATION, EYES

Abstract

Objectives: This study aims to quantitatively assess the profile of the choroidal thickness (ChT) in patients with ankylosing spondylitis (AS) using optical coherence tomography (OCT), and to examine whether the posterior eye segment abnormalities in active AS patients are reversible by infliximab therapy.